Top Markets
#1 Islamic Coin Islamic Coin +155.94%
#2 Siren Siren +37.70%
#3 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +23.25%
#4 Verus Coin Verus Coin +22.40%
#5 Cysic Cysic +19.60%
#6 OpenEden OpenEden +19.09%
#7 Ocean Protocol Ocean Protocol +14.70%
#8 Arowana Arowana +14.57%
#9 RedStone RedStone +13.95%
#10 Perle Perle +13.70%
Coin of the day
Islamic Coin Islamic Coin
Innstillinger
Språk
NORSK
Valuta
USD
Tema
Intensity Therapeutics, Inc. Intensity Therapeutics, Inc.

Intensity Therapeutics, Inc.

INTS
Rangering i aksjer #32091
Intensity Therapeutics, Inc. is a biotechnology enterprise in the clinical... Intensity Therapeutics, Inc. is a biotechnology enterprise in the clinical development phase, dedicated to discovering, advancing, and commercializing pharmaceutical treatments for solid tumor cancers. The company's primary experimental compound, INT230-6, is presently undergoing Phase 2 clinical trials. This investigational drug targets a range of difficult-to-treat solid tumors, including those affecting the pancreas, colon, bile duct, as well as squamous cell, sarcoma, breast, and liver cancers. Intensity Therapeutics has formed strategic collaborations with major pharmaceutical companies and research institutions: A partnership with Merck Sharpe & Dohme Corp. focuses on evaluating INT230-6 in conjunction with Keytruda for advanced pancreatic, colon, squamous cell, and bile duct malignancies. Another collaboration with Bristol-Myers Squibb Company is dedicated to studying INT230-6 combined with Yervoy in patients suffering from advanced liver, breast, and sarcoma cancers. Furthermore, the company is working with the Ottawa Hospital Research Institute and the Ontario Institute of Cancer Research on a randomized controlled Phase II neoadjuvant study of INT230-6 for women diagnosed with early-stage breast cancer. Established in 2012, Intensity Therapeutics maintains its corporate headquarters in Westport, Connecticut.
Aksjekurs
$4.12
Sist synkronisert: 2026-08-17
Markedsverdi
$11.14M
Endring (1 dag)
4.04%
Endring (1 år)
-45.79%
Land
US
Handel Intensity Therapeutics, Inc. (INTS)

Kategori

Healthcare
Aksjeprishistorikk for Intensity Therapeutics, Inc. (INTS)
Høyeste sluttskurs: $4.14 den 2026-08-01

Laveste sluttskurs: $149.00 den 2023-06-01
Aksjeprishistorikk for Intensity Therapeutics, Inc. fra 2023 til 2026
Årlig aksjeprisytelse
År Ytelse
2026 (TTM) -34.55%
2025 -80.08%
2024 -65.35%
2023 0.00%
Aksjepris for lignende selskaper eller konkurrenter
Selskap Aksjepris Endring 1år% Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $515.58 32.24%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $992.01 50.00%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $111.31 -36.83%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $736.64 6.99%
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 $1.06K -7.04%
KR